Publications by authors named "O Doganlar"

Article Synopsis
  • The study investigates the effects of melatonin (MEL) combined with temozolomide (TMZ) on glioblastoma and neuroblastoma cancer cell lines, aiming to understand how this combination affects cell viability and resistance.
  • Results reveal that the MEL and TMZ combination significantly decreases cancer cell viability and increases apoptosis compared to other treatments, highlighting a potential strategy to counteract drug resistance in these cancers.
  • The findings suggest that this combination therapy upregulates genes involved in antioxidant defense and DNA repair, indicating a possible mechanism through which MEL enhances the efficacy of TMZ.
View Article and Find Full Text PDF

Combinations of the well-known antineoplastic agents 5-fluorouracil (5-Fu), cisplatin, and paclitaxel are employed to increase radiotherapy/immunotherapy efficacy against persistent and resistant tumors. However, data remains needed on the hormetic, chronic, and long-term side effects of these aggressive combination chemotherapies. Here we investigated cellular and molecular responses associated with these combined agents, and their potential to induce multi-drug resistance against the temozolomide (TMZ) and etoposide (EP) used in glioblastoma maintenance treatment.

View Article and Find Full Text PDF

Study Design: This is a retrospective cohort study.

Purpose: This study aimed to clarify the role of crosstalk between discoidin domain receptors (DDRs) and matrix metalloproteinases (MMPs) in the ligamentum flavum (LF) fibrosis obtained from patients with degenerative lumbar canal stenosis (DLCS).

Overview Of Literature: The DDRs, DDR1 and DDR2, are cell surface receptors and have an essential role in collagen fiber accumulation in several fibrotic diseases.

View Article and Find Full Text PDF

Age-related macular degeneration (AMD) is one of the leading causes of blindness worldwide, particularly in developed countries. Recently, microRNAs (miRs) have become popular research area to develop new treatment options of AMD. However, interaction between hsa-miR-184 and AMD remain largely unexplored.

View Article and Find Full Text PDF